Quality of reporting inflammatory bowel disease randomised controlled trials: a systematic review.

These findings are consistent with those of other specialties in the literature. While this unclear risk of bias may represent poor reporting of methods instead of poor methodological quality, it leaves readers and future secondary researchers with significant questions regarding such key issues.